Tierney David S 4
4 · CATALYST PHARMACEUTICALS, INC. · Filed Aug 23, 2024
Insider Transaction Report
Form 4
Tierney David S
Director
Transactions
- Exercise/Conversion
Common stock, par value $0.001 per share
2024-08-21$4.01/sh+15,000$60,150→ 363,874 total - Sale
Common stock, par value $0.001 per share
2024-08-21$20.10/sh−15,000$301,455→ 348,874 total - Exercise/Conversion
Options to purchase common stock
2024-08-22+15,000→ 188,931 totalExercise: $4.01Exp: 2025-01-02→ Common Stock (15,000 underlying)
Footnotes (3)
- [F1]Shares were sold on the open market for personal reasons and not as a result of any disagreement with the Company.
- [F2]Represents a weighted average price for the shares sold. Shares were sold in various lots ranging from $20.00 to $20.485 per share.
- [F3]Options vested in three annual tranches beginning on January 2, 2019.